Policy briefing. Women who inject drugs and HIV: addressing specific needs. by unknown
1. Needle and syringe programmes (NSPs)
2. Opioid substitution therapy (OST) and 
other evidence-based drug dependence 
treatment
3. HIV testing and counselling (HTC)
4. Antiretroviral therapy (ART)
5. Prevention and treatment of sexually 
transmitted infections (STIs)
6. Condom programmes for people who 
inject drugs and their sexual partners
7. Targeted information, education and 
 communication (IEC) for people who 
inject drugs and their sexual partners
8. Prevention, vaccination, diagnosis and 
treatment for viral hepatitis
9. Prevention, diagnosis and treatment of 
tuberculosis (TB)
INTRODUCTION AND OVERVIEW
Issue summary: the 
 vulnerabilities of women 
who inject drugs
Throughout the world, people who inject drugs 
(PWID) are all too familiar with stigmatization, 
vulnerability, marginalization and high risk for 
HIV. The situation is even worse for women 
who inject drugs (WID), who are often ignored 
and invisible within the larger drug-using pop-
ulation. National and international research, 
services, guidelines, training programmes and 
surveillance concerning people who inject 
drugs remain overwhelmingly gender-neutral 
or male-focused. Partly as a result, limited data 
exist on the role women play among those who 
inject drugs, and their specific challenges and 
needs are rarely recognized or understood.
The health and human rights impacts of such 
invisibility can be very harmful. Women who 
inject drugs face a range of gender-specific 
 barriers to accessing HIV-related services, and in 
many contexts they remain a particularly hard-
to-reach population, even where harm reduction 
programmes are in place. The stigma and dis-
crimination that they experience, which is often 
heightened by gender-based violence and abuse, 
increases their risk for contracting HIV and 
other blood-borne viruses, as well as a wide 
range of sexually transmitted infections (STIs).1
For the purposes of this policy brief, harm 
reduction services are defined by the interven-
tions included in the Comprehensive Package, 
as detailed in the WHO/UNODC/UNAIDS Tech-
nical guide for countries to set targets for uni-
versal access to HIV prevention, treatment and 
care for injecting drug users:2 
To date, inadequate attention has been given 
to rectifying gender inequalities in harm 
reduction programming. Strategies and poli-
cies are urgently needed to address this gap 
as a first step towards improving the safety, 
health and well-being of women who inject 
drugs. Additional approaches should also be 
developed and implemented to provide compre-
hensive health, social and legal services that 
reach them and their sexual and drug-using part-
ners. To be effective, such approaches should be 
based on evidence and human rights standards. 
These steps are necessary not only for women 
who inject drugs, but also more broadly for 
communities and societies. Failure to ade-
quately respond to the needs of this invisible 
and highly vulnerable population has harmful 
consequences for the health of the individuals 
themselves as well as for public health overall. 
POLICY BRIEF
Women who inject  
drugs and HIV:  
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Women comprise a growing 
share of people who inject drugs
No global population size estimates of women who 
inject drugs are available, and data gaps exist in nearly 
all countries. Their numbers are considerable never-
theless. According to one recent estimate, women’s 
share of people who inject drugs ranges from at least 
10 per cent to over 30 per cent in some parts of Europe, 
and is around 20 per cent in Eastern Europe, Central 
Asia and Latin America; 10-20 per cent in parts of 
Africa; 20 per cent in China and Viet Nam, and at least 
10 per cent in other parts of Asia.5 Moreover, recent 
surveys suggest that the proportion of women who use 
drugs in general is growing.6
Women have more and different 
barriers to accessing services
Women who inject drugs often have limited or no 
access to harm reduction or general health services. 
This situation is especially acute in many countries 
with concentrated HIV epidemics among people who 
inject drugs. Harm reduction coverage in most low- 
and middle-income countries remains insufficient to 
reduce the prevalence of HIV and viral hepatitis epi-
demics among all people who inject drugs.7,8 But 
access is even worse for women. For example, on 
average in Eastern Europe, less than 1 per cent of 
people who inject drugs—and only 0.003 per cent of 
women who inject drugs—are estimated to have 
access to opioid substitution therapy (OST).9
Women who inject drugs have particular needs and 
risk factors that are different from those of men who 
inject drugs. Many are engaged in sex work regularly 
or occasionally, which adds to their HIV transmission 
risk.10,11 In addition to having poor access to sterile 
injecting equipment and to condoms, women who 
inject drugs also have relatively limited access to a 
standard set of sexual and reproductive health ser-
vices and to special programmes aimed at preventing 
mother-to-child transmission of HIV. Therefore, verti-
cal transmission rates among women who use drugs 
and who are living with HIV are significantly higher 
than among women living with HIV without a history 
of drug use.12,13 Other needs and risk factors particular 
to women (mostly) include intimate partner violence 
and fear of loss of custody of children. 
Women who inject drugs report that they feel left 
out of existing harm reduction programmes and 
interventions.14,15,16 Harm reduction services, includ-
ing in prison settings, are generally tailored primarily 
or exclusively towards men who inject drugs.17,18 Some 
programmes, for example, do not guarantee personal 
safety and confidentiality with women-only spaces or 
times. Often they do not have appropriately trained 
staff, including women with a history of drug use. 
Services such as child care and interventions for 
women who are sex workers and who have experi-
enced violence may not exist. 
About this document
This policy brief aims to promote the realization of 
gender equality and human rights in terms of an 
effective harm reduction response to HIV for women 
who inject drugs in community and prison settings. 
It outlines a framework to achieve that goal which 
focuses on improving the availability, accessibility, 
affordability and acceptability of women-oriented 
harm reduction interventions. Suggested good prac-
tice tools and guidance are also provided.
This document is intended primarily for policy-
makers and programme managers to inform deci-
sions on HIV services at national and local levels 
within countries.3 It is based on existing United 
Nations guidance documents. The policy brief is 
accompanied by a practical guide for governmen-
tal and non-governmental service providers on 
interventions addressing the needs of women who 
inject drugs.4
PUTTING THE FOCUS ON WOMEN  
Key reasons and unique challenges
This section discusses some of the main reasons that greater attention and resources should be directed towards 
women who inject drugs. Most underscore the unique and often “additional” challenges and obstacles that 
women face within drug-using communities and in societies overall. A vital message is that the lack of targeted 
focus means that they are and will remain more vulnerable and at risk than their male counterparts in nearly all 
aspects of their lives.
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Violence against women who 
inject drugs 
Violence against women is a critical issue that 
deserves special attention when considering barriers 
and obstacles to adequate services and support. 
Women who inject drugs experience high rates of 
intimate partner violence,19 which negatively affects 
their ability to practise safe sex20 and safer drug 
use.21 Punitive policies are frequently associated with 
police abuses, including physical and sexual violence 
against women who inject drugs.22,23 Gender-related 
violence of this kind makes women reluctant to 
access harm reduction services even if they are 
available, often because they fear being harassed or 
abused simply for trying to enter facilities.24 
Legal and policy-related barriers
Numerous policy-related barriers directly and indi-
rectly affect the health of women who inject drugs and 
further violate their basic human rights. Collectively, 
they represent major obstacles to their ability to 
obtain essential services to protect their own health 
and the health of others in their lives.
The criminalization of drug use heavily influences 
the accessibility of harm reduction services.25,26  Simi-
larly, legal frameworks can obstruct the provision of 
services for all people who inject drugs, such as 
where police arrest health workers supplying ster-
ile injecting equipment and individuals who possess 
the equipment.27 However, some policies, practices 
or laws have different, and often more profound 
and debilitating, impacts on women. 
For example, women who inject drugs who are also 
sex workers are further stigmatized due to the addi-
tional negative impact of the criminalization of sex 
work. In such contexts, they are even more restricted 
in their access to HIV-related services and their 
capacity to negotiate condom use.28 Other laws and 
policies that affect women include those indicating 
drug use as criteria for loss of child custody, for 
forced or coerced sterilization, or for abortion. Poli-
cies such as drug user registration further discour-
age women from accessing services, because their 
registration can lead to a loss of child custody and 
other forms of enduring discrimination.29 In some 
countries, laws and policies require women to have 
permission from family members or spouses to 
access health services. 
Selected international standards, 
agreements and human rights mechanisms 
that support gender-sensitive harm 
reduction policy and services
UNAIDS, Programme Coordinating Board, Thirty-
first Meeting, agenda item 2, UNAIDS Agenda for 
Accelerated Country Action for Women, Girls, 
Gender Equality and HIV Mid-term Review – Final 
report, 29 November 2012, UNAIDS/PCB(31)/ 
12.20 (para. 95)
•
Women out loud: How women living with HIV 
will help the world end AIDS, Reaching the ten 
targets of the 2011 United Nations General 
Assembly Political declaration on HIV and AIDS, 
2012 (Target 2)
•
Agreed conclusions of the Commission on the 
Status of Women on thematic issues: Women, the 
girl child and human immunodeficiency virus/
acquired immunodeficiency syndrome, 5th Ses-
sion (6-16 March and 9-11 May 2001), E/2001/
INF/2/Add.2 (para. 4 (j))
•
Report to the Human Rights Council, Report of 
the Special Rapporteur on the right of everyone 
to the enjoyment of the highest attainable stand-
ard of physical and mental health, Anand Grover, 
Addendum, Mission to Viet Nam, 4 June 2012, 
A/HRC/20/15/Add.2 (para. 63 (b))
•
Committee on the Elimination of Discrimination 
against Women, Concluding observations on the 
State report of Brazil, 23 March 2012, CEDAW/C/
BRA/CO/7 (para. 32)
•
Committee on Discrimination against Women, 
Concluding observations on the State report of 
the United Kingdom of Great Britain and 
Northern Ireland, 10 June 1999, CEDAW/C/UK/3 
and CEDAW/C/UK/4 (para. 313)
•
Promoting strategies and measures addressing 
specific needs of women in the context of com-
prehensive and integrated drug demand reduction 
programmes and strategies, 2012, CND Resolu-
tion 55/5 (para. 4)
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Some improvements for women who inject drugs 
may occur if and when the comprehensive harm 
reduction package and other services are expanded 
for all people who inject drugs. But this is not nearly 
enough: the needs and rights of women who inject 
drugs cannot be fully met without the provision of 
targeted services.
Increased awareness, knowledge and commitment 
are essential to overcome the challenges mentioned 
above. Listed below are some priority focus areas 
that policymakers should consider.
Paucity of data on women who 
inject drugs 
Out of the 84 countries reporting to the Joint United 
Nations Programme on HIV/AIDS (UNAIDS) on HIV 
prevalence in 2012, only 15 reported prevalence 
among women who inject drugs. Most countries do 
not collect gender-disaggregated data on needle 
and syringe programmes (NSPs), opioid substitu-
tion therapy (OST) or antiretroviral therapy (ART) 
coverage. In order to effectively meet the needs of 
all at risk, especially members of highly vulnerable 
populations, national HIV policymakers need to 
“know their epidemic and response”. The Techni-
cal guide for countries to set targets for universal 
access to HIV prevention, treatment and care for 
injecting drug users—a joint project of WHO, 
UNODC and UNAIDS30—recommends that data dis-
aggregated by gender should be collected to assess 
and monitor any disparity in harm reduction ser-
vice access.
Gender-specific harm reduction 
interventions
Harm reduction interventions for all people who inject 
drugs should be offered on a voluntary basis in an 
enabling environment created by supportive policies 
and strategies. These interventions should be physi-
cally accessible, affordable, available on a regular 
basis to all in need (i.e. not rationed) and offered in a 
non-judgemental manner. Furthermore, access to the 
interventions included in the Comprehensive Package 
should not be restricted by socio-demographic or 
other criteria, such as sex/gender, employment status 
and profession—including sex work or imprisonment, 
substance use status or pregnancy status.30
The gender-oriented priorities specified in the Com-
prehensive Package have long been echoed in other 
forums and documents. Numerous international 
standards, agreements and human rights mecha-
nisms support gender-sensitive harm reduction pol-
icy and services. For example, resolution 55/5 of 
the Commission on Narcotic Drugs (CND) in 2012 
states the following: “Also recommends that Mem-
ber States, in designing, implementing and evaluat-
ing integrated drug prevention and treatment and 
HIV prevention programmes, take into account the 
needs of women who have experienced sexual and 
other violent trauma related to drug abuse.”31
To date, though, gender-specific harm reduction 
programming has been under-resourced. Where 
available, it is often not integrated within national 
HIV strategies.32 Lack of focus on developing and 
implementing gender-specific interventions repre-
sents missed opportunities for improved health out-
comes. Experience from gender-specific programmes 
for women who inject drugs demonstrates that they 
are effective in improving access and service 
uptake. For example, clinics in Iran have been 
designed specifically for women who use drugs, and 
provide a range of services, including OST. This has 
resulted in decreases in heroin use, high-risk inject-
ing practices and involvement in crime among cli-
ents.33 In Ukraine, for example, tailored medical 
and social services for women who inject drugs 
have significantly exceeded the intended coverage 
for vulnerable women.34
Many of the interventions offered by such pro-
grammes are referred to in table 1 below, which 
highlights some good practice elements aimed at 
addressing the specific needs of women who inject 
drugs. A key objective is to ensure gender equality 
across all nine harm reduction components. 
Gender mainstreaming in harm 
reduction
The term “gender mainstreaming” is used to refer 
to a strategy for recognizing, responding to and 
integrating the needs and concerns of both women 
and men in programmes and policies at all levels.35 
It aims to achieve gender equality, which is pro-
moted by a solid body of international law.36,37 Yet, 
despite the commitment of nearly all countries to 
gender equality, laws and policies that present 
IMPROVING THE SITUATION  
Priority approaches and strategies
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Table 1.  COMPREHENSIVE HARM REDUCTION PACKAGE COMPONENTS AND 
KEY INTERVENTIONS FOR WOMEN WHO INJECT DRUGSa
1. Harm reduction components 2. Interventions responding  
to the needs of women  
who inject drugs
3. Key implementation 
considerations
Needle and syringe programmes 
(NSPs)
Opioid substitution therapy (OST) 
and other evidence-based drug 
dependence treatment
HIV testing and counselling (HTC)
Antiretroviral therapy (ART)
Prevention and treatment of 
sexually transmitted infections 
(STIs)
Condom programmes for people 
who inject drugs and their sexual 
partners
Targeted information, education 
and communication (IEC) for 
people who inject drugs and their 
sexual partners
Prevention, vaccination, diagnosis 
and treatment for viral hepatitis
Prevention, diagnosis and 
treatment of tuberculosis (TB)
Sexual and reproductive health, 
including services for STIs and 
prevention of mother-to-child 
transmission (PMTCT) 
Maternal and child health
Gender-specific peer education 
and support
Gender-based violence-related 
services
Services tailored for women who 
inject drugs who are also 
engaged in sex work
Provision of female condoms
Parenting support
Child care
Couples counselling (aimed at 
ensuring that the responsibility 
for reducing HIV and health risks 
is equally shared between both 
partners)
IEC that is specifically relevant to 
women who inject drugs (includ-
ing safer injecting and safer sex 
techniques)
Legal aid (attuned to be acces-
sible and relevant to the needs of 
women who inject drugs)
Provision of psychosocial and 
ancillary services and 
commodities
Income-generation interventions 
for women who inject drugs
Service delivery and integration
Discreet and accessible service 
locations
Women-only spaces and/or times 
at drop-in centres or separate 
venues
Specific outreach for women who 
inject drugs
Collaboration and cross-referral 
with programmes addressing sex 
work and HIV
Secondary needle and syringe 
distributionb
Addressing stigma and 
discrimination
Advocacy for improved services 
and the elimination of policy, 
legal and social obstacles 
Resourcing
Data
Participatory planning, implemen-
tation and evaluation
NOTE: Where interventions listed in 
columns 1 and 2 of this chart cannot be 
included on-site, strong referral linkages 
should be developed with relevant service 
providers as available.
aThese elements are detailed further in the UNODC practical guide for governmental and non-governmental service providers on interven-
tions addressing the needs of women who inject drugs.
bSecondary distribution involves peer outreach workers as well as other services, such as sexual health clinics, drug dependence treatment 
services and hospital emergency services. It is an important approach, because it can help maximize the accessibility of sterile injecting 
equipment.
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barriers to the delivery of services to women are 
still common in some parts of the world.
In order to mainstream gender equality across the 
nine harm reduction components specified in 
table  1, policymakers should work to improve the 
availability, accessibility, affordability and accept-
ability of all the components for women who inject 
drugs. Also essential to understand in different con-
texts are the gender roles and inequalities that exist 
in communities of people who inject drugs and in 
societies more broadly. This is particularly relevant 
for harm reduction planning and programming, 
because structural gender inequalities tend to be 
closely related to the injecting and sexual practices 
that contribute to HIV risk. 
The establishment of strong working linkages with 
other services can help ensure more thorough gender 
mainstreaming of harm reduction programmes. Other 
services might include those for sexual and reproduc-
tive health, maternal and child health,  gender-based 
violence, legal support and evidence-based drug 
dependence treatment. Where such elements are 
“outsourced” from harm reduction programmes, the 
linkage-strengthening process should include staff 
training to build capacity for service delivery that is 
acceptable and friendly for women who inject drugs. 
Further integration of gender-specific services can be 
achieved by introducing harm reduction elements for 
women who inject drugs into other health services, 
such as providing opioid substitution therapy (OST) in 
maternity hospitals.
And finally, it is critical to support meaningful 
involvement of women who inject drugs at all levels 
and stages in developing and implementing policy 
that may have an impact on them. Failure to seek 
and include their input will likely result in insufficient 
or inadequate approaches.
Resource mobilization for 
gender-specific harm reduction 
programming
The severe underfunding of harm reduction around 
the world remains a major barrier to scaling up HIV 
prevention, treatment and care for people who 
inject drugs.38 The lack of investment in developing 
targeted services for women who inject drugs is 
even more acute.39
Specific investment is needed to ensure that women 
have access to harm reduction services that meet 
their needs. However, such funding will only 
achieve optimal impacts where resource mobiliza-
tion is undertaken in tandem with efforts to iden-
tify and overcome service access barriers. In order 
to identify funding gaps and ensure that funding is 
proportionate to need, better investment tracking 
and a greater awareness is needed among govern-
ments of both their overall harm reduction invest-
ment  and their specific investment in harm 
reduction for women.
Incarceration, women who inject 
drugs and harm reduction 
An increasing number of women are being incarcer-
ated for drug-related offences worldwide.40 In fact, 
drug offences are one of the primary reasons why 
women enter the prison system.41 For example, in 
several Latin American countries, between 60 per cent 
and 80 per cent of women are incarcerated for drug-
related offences.42 In Europe and Central Asia, more 
than 25 per cent (and up to 70 per cent in Tajikistan) 
of women prisoners were convicted of a drug-related 
offences. 
Given the close linkages between illicit drug use 
and incarceration, and taking into account health 
and human rights perspectives and the widespread 
availability of narcotics in most prisons, it is 
important that prison systems provide access to 
the Comprehensive Package of harm reduction 
interventions and health services equivalent to 
those available in the community. In addition to the 
harm reduction components as listed in the Tech-
nical guide for countries to set targets for univer-
sal access to HIV prevention, treatment and care 
for injecting drug users,43 UNODC details a prison-
specific comprehensive package of 15 specific inter-
ventions required to respond to HIV in closed 
settings (along with recommendations concerning 
gender responsiveness and broader prison and 
criminal justice reforms).44 
These evidence-based recommendations are infre-
quently adopted, however. In many countries, 
harm reduction interventions, including opioid 
substitution therapy, are not available in women’s 
prisons.45
Introducing comprehensive harm reduction ser-
vices in women’s prisons is only one part of a more 
enlightened and effective overall strategy. For soci-
eties overall, social, health and economic outcomes 
would improve if fewer women who use drugs were 
incarcerated. Achieving this goal requires a close 
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Country-level strategic planning should be directed 
towards taking action in response to the suggestions 
below and achieving universal access to HIV preven-
tion treatment care and support for women who 
inject drugs.
To this end, a national coordination mechanism 
should be established that is composed of key 
national stakeholders representing at the highest 
level the health ministries, national HIV/AIDS 
authorities and government agencies responsible 
for women’s affairs, the judiciary, penal institutions 
and illicit drugs. The public sector cannot and should 
not act alone, however. Civil society and community 
groups, in particular those for and including 
women who inject drugs, should be involved in all 
stages of planning and implementing initiatives and 
strategies. Their engagement is vital to help ensure 
that steps taken are acceptable among the intended 
beneficiaries and thus are as effective as possible.
The following actions should be integrated in 
national AIDS plans, as well as other relevant pro-
gramming and planning areas (for example, for penal 
systems). Resources should be allocated for their 
implementation.
and realistic look at existing harsh policies in many 
contexts. In most cases, drug offences committed 
by women are related to personal drug use and 
possession of small amounts of drugs, with no 
intent to sell. Most of these women have not com-
mitted any violent crime46—and for example, in 
Latin America, most incarcerated women are first-
time offenders.47 Given that women are often 
responsible for the household and children, incar-
ceration for lengthy periods of time may result in 
children either accompanying their mother to 
prison or ending up on the street.48
In prison, women often have a higher prevalence of 
blood-borne viruses and STIs and more health prob-
lems than male inmates.49,50 Further, women in prison 
experience a variety of other harms, including the loss 
of custody of their children and sexual violence.51 
Upon release, the stigma of imprisonment weighs 
more heavily on women than on men. In some coun-
tries, women are discriminated against and unable to 
return to their communities after being released from 
prison. Women in closed settings, including in com-
pulsory “rehabilitation” centres,52,53,54 are particularly 
vulnerable to sexual violence and abuse.
Most female drug offenders could be 
dealt with more effectively by alterna-
tives to imprisonment specifically  
targeting the drug problem rather  
than imprisonment.55
The United Nations Standards for the Treatment of 
Women Prisoners and Non-custodial Measures for 
Women Offenders (“the Bangkok Rules”)56 promote 
alternatives to prison sentences for women and 
emphasize the importance of appropriate health 
care, humane treatment, preserving dignity during 
searches, protection from violence and provision 
for children of incarcerated women.
1. Collect gender-specific strategic information 
• Collect sex-disaggregated data on drug use, HIV prevalence and coverage of harm reduction services 
components (as listed in table 1), including in prisons.
• Identify and fill research gaps to improve understanding of the needs of women who inject drugs. 
This is necessary to inform evidence-based service provision.
Data collection methodologies should be rigorous and transparent. A lack of data does not constitute a reason 
to delay implementation of gender-specific harm reduction interventions.
The way forward
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2. Mainstream harm reduction interventions for women who inject drugs
• Introduce/expand and integrate gender-specific elements (see table 1) within all harm reduction ser-
vices, including in prisons and pre-trial detention centres. 
• Develop specific guidelines, indicators and targets that address the needs of women who inject drugs 
with regard to harm reduction services, sexual and reproductive health, pre- and post-natal care and 
other key interventions (as listed in columns 1 and 2 of table 1).
• Prison systems should provide access to the Comprehensive Package of harm reduction interventions 
and health services equivalent to those available in the community, including during pre-trial deten-
tion, and ensure that no interruptions of ART and OST occur in any settings associated with detention 
(including pre-sentencing).
• Provide sexual and reproductive health care, psychosocial support and other forms of gender- sensitive 
care in women’s prisons and pre-trial detention centres.
3. Strengthen capacity and increase resources 
• Establish functional working partnerships and policy harmonization across all relevant stakeholder 
ministries, including justice, corrections, health, women’s affairs and social welfare. Such partner-
ships should include the non-governmental sector as well, including community-based organiza-
tions that focus on gender equality, harm reduction services and women’s health.
• Train harm reduction service staff to deliver gender-specific services.
• Ensure that law enforcement training curricula and health-care staff training curricula include mater-
ials on the needs and rights of women who inject drugs, stigma reduction and appropriate referrals to 
harm reduction services.
• Allocate resources to introduce and expand gender-specific harm reduction service provision for 
women who inject drugs. 
• Integrate gender analysis into policy and programme planning and monitoring and evaluation frame-
works, and build capacity to address gender inequalities faced by women who inject drugs.
4. Create an enabling policy environment
• Ensure that HIV policy and programme planning are in line with international guidance and proto-
cols, including human rights mechanisms.57
• Legislation, procedures, policies and practices should be reviewed to determine if they have a negative 
impact on women. Those found lacking should be modified in order to ensure that women are treated 
fairly by health, welfare, law enforcement and criminal justice systems. For example, drug use status 
should not be used as a criterion for loss of child custody or access to health and social services.
• Involve and support organizations representing women who inject drugs in programme design, imple-
mentation, monitoring and evaluation. 
• Effective and humane approaches should be considered, including diversionary measures, senten-
cing substitutes and decriminalization of drug use. 
• Implement and enforce measures aimed at preventing violence and abuse, including sexual violence, 
both in society overall and within prisons specifically.
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Tools and resources 
The following list of tools and further reading may provide support and ideas for improving comprehensive 
service provision for women who inject drugs. Examples may be relevant for, among other things, policy and 
programme development, implementation, and monitoring and evaluation (M&E).
A key reference addressing harm reduction data collection, components and targets for people who inject 
drugs in community and prison settings:
• Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug 
users. 2012 Revision (WHO, UNODC, UNAIDS). Available at http://apps.who.int/iris/bitstream/10665/77969/1/9789241504379_
eng.pdf
For programmatic orientation
• “Developing effective harm reduction services for women who inject drugs” (Pinkham S., Myers B., Stoicescu C.), in The 
global state of harm reduction: Towards an integrated response (Harm Reduction International, 2012). Available at http://www.
ihra.net/global-state-of-harm-reduction-2012 (The chapter sets out a menu of services for women who inject drugs in terms of 
adjustments to existing services, adding new elements to services or implementing new stand-alone services. See p. 133.)
• Good practice guide: HIV and drug use − Community responses to injecting drug use and HIV (The International HIV/
AIDS Alliance, 2010). Available at http://www.aidsalliance.org/includes/Publication/GPG_drug%20use_07.06.12.pdf
• Integrating gender into HIV/AIDS programmes in the health sector. Tool to improve responsiveness to women’s needs 
(WHO, 2009). Available at http://www.who.int/gender/documents/gender_hiv/en/
For prison settings
• The United Nations Rules for the Treatment of Women Prisoners and Non-custodial Measures for Women Offenders 
(“the Bangkok Rules”). Available at http://www.penalreform.org/priorities/women-in-the-criminal-justice-system/bangkok-
rules-2/ (This site also provides a number of tools to guide implementation of the Rules.)
• Women and HIV in prison settings (UNODC, UNAIDS, Vienna, 2008). Available at http://www.unodc.org/documents/hiv-aids/
Women%20and%20HIV%20in%20prison%20settings.pdf
• HIV prevention, treatment and care in prisons and other closed settings: a comprehensive package of interventions, 
policy brief (UNODC, ILO, UNDP, WHO, UNAIDS, 2013). Available at http://www.unodc.org/documents/hiv-aids/HIV_compre-
hensive_package_prison_2013_eBook.pdf (The publication lists 15 specific prison-specific interventions that are considered 
necessary to respond properly to HIV in closed settings, along with recommendations concerning gender responsiveness and 
broader prison and criminal justice reforms. A number of additional tools are listed within the brief.)
• Handbook for prison managers and policymakers on women and imprisonment (UNODC, 2008). Available at http://www.
unodc.org/documents/justice-and-prison-reform/women-and-imprisonment.pdf
For monitoring and evaluation
• On course: Mainstreaming gender into national HIV strategies and plans. A roadmap (UNDP, 2012). Available at 
http://asapltd.com/wp-content/uploads/2013/07/UNDP-Roadmap-12-11-2012-final.pdf
• Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug 
users, 2012 Revision (WHO, UNODC, UNAIDS). Available at http://apps.who.int/iris/bitstream/10665/77969/1/9789241504379_
eng.pdf
For policy-related advocacy
• Handbook of basic principles and promising practices on alternatives to imprisonment (UNODC, 2007). Available at 
http://www.unodc.org/pdf/criminal_justice/Handbook_of_Basic_Principles_and_Promising_Practices_on_Alternatives_to_
Imprisonment.pdf. (The handbook includes special sections on both people who inject drugs and women.)
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